Scholarlink

<p>Ischemic diseases, especially coronary artery diseases and myocardial infarction, are the leading cause of human death in the clinical setting. Unfortunately, most of the available clinical interventions can partially restore the function of ischemic myocardium, resulting in the progression of chronic heart failure.The induction of vascular tissue formation, hereafter known as angiogenesis, can provide blood perfusion and prevent the expansion of ischemia-related pathologies. In recent years, the discovery and advent of multiple stem cells into human regenerative medicine have led to the alleviation of certain end-stage pathological conditions via direct differentiation into the mature and functional cells or secretion of various cytokines and angiogenesis factors in a paracrine manner. Melatonin (mel) is a natural molecule with direct and indirect pleiotropic actions on different biological phenomena. This neurohormone is primarily known for its antioxidant, tumoricidal, and anti-inflammatory actions in several pathological conditions. Whether and how mel regulates the angiogenesis behavior of stem cells is currently under debate. Here, we collected and evaluated recent data related to the angiogenic properties of mel on stem cells. Data from the present article may help us in the development of new therapeutic regimes in patients with ischemic conditions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Melatonin and angiogenesis potential in stem cells

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月5日

查看全文
  • Somayyeh Rashidi,
  • Sara Aghakhani Chegeni,
  • Golbarg Roozbahani,
  • Reza Rahbarghazi,
  • Aysa Rezabakhsh,
  • Russel J. Reiter

摘要

Ischemic diseases, especially coronary artery diseases and myocardial infarction, are the leading cause of human death in the clinical setting. Unfortunately, most of the available clinical interventions can partially restore the function of ischemic myocardium, resulting in the progression of chronic heart failure.The induction of vascular tissue formation, hereafter known as angiogenesis, can provide blood perfusion and prevent the expansion of ischemia-related pathologies. In recent years, the discovery and advent of multiple stem cells into human regenerative medicine have led to the alleviation of certain end-stage pathological conditions via direct differentiation into the mature and functional cells or secretion of various cytokines and angiogenesis factors in a paracrine manner. Melatonin (mel) is a natural molecule with direct and indirect pleiotropic actions on different biological phenomena. This neurohormone is primarily known for its antioxidant, tumoricidal, and anti-inflammatory actions in several pathological conditions. Whether and how mel regulates the angiogenesis behavior of stem cells is currently under debate. Here, we collected and evaluated recent data related to the angiogenic properties of mel on stem cells. Data from the present article may help us in the development of new therapeutic regimes in patients with ischemic conditions.